E2F7/RAD51AP1轴通过脂肪酸代谢途径抑制子宫内膜癌对5-FU的敏感性
Xiaoyan Huang1, Zaixin Wu2, Chunhong Xiao3
1Department of Oncology, 900TH Hospital of Joint Logistics Support Force, Fuzhou, P.R. China; huangxiaoyan122022@163.com.
Anticancer research
|November 1, 2023
概括
通过改变脂肪酸代谢,E2F7/RAD51AP1轴促进子宫内膜癌 (EC) 的生长,并降低5-甲 (5-FU) 的敏感性. 这一途径为EC治疗提供了潜在的新目标.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症生物学 癌症生物学
- 分子治疗学分子治疗学
背景情况:
- 子宫内膜癌 (EC) 对5-甲 (5-FU) 化疗的敏感性降低,需要对潜在的耐药机制进行研究.
- 研究影响EC对5-FU反应的因素对于提高治疗疗效至关重要.
研究的目的:
- 探索由E2F7转录激活的RAD51AP1在对5-FU的EC敏感性中的作用.
- 阐明脂肪酸代谢途径在E2F7/RAD51AP1介导的5FU反应调节中的参与.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据在EC中进行差异基因表达分析.
- 为了验证E2F7-RAD51AP1相互作用,使用了生物信息学,qRT-PCR,西部斑,ChIP和双化酶试验.
- 通过CCK-8测定,通过流式细胞计量进行细胞亡,以及与亡和脂肪酸代谢相关的蛋白质表达,评估了5-FU敏感性.
主要成果:
- 生物信息学分析显示,EC中E2F7和RAD51AP1的高表达,预测有结合点.
- 奇普和双化酶试验证实,E2F7直接与RAD51AP1促进体结合.
- 过度表达RAD51AP1增强了EC细胞生长和脂肪酸代谢,同时降低了5-FU灵敏度;E2F7沉默抵消了这些影响.
结论:
- 通过调节脂肪酸代谢,E2F7/RAD51AP1轴促进EC细胞生长,并降低对5-FU的敏感性.
- 该E2F7/RAD51AP1通路代表了一个潜在的新型治疗点,用于子宫内膜癌.
相关概念视频
Electron Transport Chain: Complex I and II
14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.2K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


